Literature DB >> 2104779

Unconjugated pteridines and the activation of macrophages by interferon gamma.

G Reibnegger, D Fuchs, A Hausen, E R Werner, G Werner-Felmayer, H Wachter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2104779     DOI： 10.1007/bf00684893

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  13 in total

1.  THE STRUCTURE OF THE PHENYLALANINE-HYDROXYLATION COFACTOR.

Authors:  S KAUFMAN
Journal:  Proc Natl Acad Sci U S A       Date:  1963-12       Impact factor: 11.205

Review 2.  Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application.

Authors:  H Wachter; D Fuchs; A Hausen; G Reibnegger; E R Werner
Journal:  Adv Clin Chem       Date:  1989       Impact factor: 5.394

3.  Human macrophages degrade tryptophan upon induction by interferon-gamma.

Authors:  E R Werner; G Bitterlich; D Fuchs; A Hausen; G Reibnegger; G Szabo; M P Dierich; H Wachter
Journal:  Life Sci       Date:  1987-07-20       Impact factor: 5.037

4.  The transport of pteridines in CCRF-CEM human lymphoblastic cells.

Authors:  S Webber; R Nazarbaghi
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Clinical significance of neopterin for prognosis and follow-up in ovarian cancer.

Authors:  G Reibnegger; H Hetzel; D Fuchs; L C Fuith; A Hausen; E R Werner; H Wachter
Journal:  Cancer Res       Date:  1987-09-15       Impact factor: 12.701

6.  Urinary excretion levels of unconjugated pterins in cancer patients and normal individuals.

Authors:  B Stea; R M Halpern; B C Halpern; R A Smith
Journal:  Clin Chim Acta       Date:  1981-07-01       Impact factor: 3.786

7.  Serum levels of neopterin as related to the prognosis of human prostatic carcinoma.

Authors:  A Lewenhaupt; P Ekman; P Eneroth; A Eriksson; B Nilsson; L Nordström
Journal:  Eur Urol       Date:  1986       Impact factor: 20.096

8.  Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix.

Authors:  G J Reibnegger; A H Bichler; O Dapunt; D N Fuchs; L C Fuith; A Hausen; H M Hetzel; H Lutz; E R Werner; H Wachter
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

9.  Folate and pterin metabolism by cancer cells in culture.

Authors:  B Stea; P S Backlund; P B Berkey; A K Cho; B C Halpern; R M Halpern; R A Smith
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

10.  [Increased urinary excretion of neopterin in patients with malignant tumors and with virus diseases (author's transl)].

Authors:  H Wachter; A Hausen; K Grassmayr
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1979-12
View more
  2 in total

1.  Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk.

Authors:  Elena Vendrame; Shehnaz K Hussain; Elizabeth Crabb Breen; Larry I Magpantay; Daniel P Widney; Lisa P Jacobson; Daina Variakojis; Emilee R Knowlton; Jay H Bream; Richard F Ambinder; Roger Detels; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-11-12       Impact factor: 4.254

Review 2.  The duality of PRDM proteins: epigenetic and structural perspectives.

Authors:  Federico Di Tullio; Megan Schwarz; Habiba Zorgati; Slim Mzoughi; Ernesto Guccione
Journal:  FEBS J       Date:  2021-05-19       Impact factor: 5.622
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.